Fast-food chain McDonald’s, an economic indicator because of its mammoth global presence, posted its worst earnings report since 2020.
Our daily email brings you smart and engaging news and analysis on the biggest stories in business and finance. For free.
The focus will be on mining earth metals including lithium, zinc, copper and nickel, all crucial metals for battery-making.
It’s basic Newtonian physics, as Boeing just learned: When the sky falls for a company, so, too, will the bottom line.
Some 8,000 industry movers and shakers are expected today for the annual JPMorgan Healthcare Conference, or simply JPM.
Novo Nordisk, maker of weight-loss drug Wegovy, struck a deal with online telehealth storefronts that sold cheap knockoffs during shortages.
Owning a Rolls-Royce is pretty good. But is it really that impressive when you could have a unique Rolls-Royce?
Novo Nordisk on Wednesday announced an expanded deal with healthtech firm Valo Health to use AI to fuel drug discovery.
A spill of new data Wednesday sent oil futures slipping and sliding in opposite directions. So is Big Oil’s tank is half-full or half-empty?
Reducing beverage-wait times is part of Starbucks CEO Brian Niccol’s turnaround plan, which includes tech updates focused on efficiency.
Alico, a major supplier to Tropicana, announced Monday that it is sunsetting its citrus business in the Sunshine State.
The deal puts an end to Fubo’s ongoing lawsuit that sought to block Disney’s efforts to build Venu Sports with Fox and Warner Bros. Discovery.
Despite China’s overall economy coming down with a bad cold last year, its EV players are upstaging the world’s most valuable auto company.
To prepare for a slowdown of global trade, US retailers spent months building a massive inventory to prevent empty shelves.
Hertz’s recent track record leaves much to be desired: the rental-car company lost nearly $2.9 billion last year.
Investor worries about a fresh batch of US tariffs have dragged LVMH shares in Paris down 23.6% so far this year.
The company plans to seek regulatory approval for the revolutionary weight loss treatment by the end of the year.